ARTICLE | Clinical News
CyclASol: Phase II started
February 22, 2016 8:00 AM UTC
Novaliq began a double-blind, placebo-controlled, U.S. Phase II trial to compare 2 dose levels of twice-daily topical CyclASol vs. open-label Restasis cyclosporine ophthalmic emulsion 0.05% in about ...